The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.175 (10.45%)
Spread: 0.10 (5.556%)
Open: 1.75
High: 1.925
Low: 1.70
Prev. Close: 1.675
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Returns

31 May 2023 07:00

RNS Number : 0413B
Genedrive PLC
31 May 2023
 

 

genedrive plc

("genedrive" or the "Company")

 

Block Listing Returns

 

The Company confirms the block listing six monthly return for the period to 31 May 2023.

 

Name of applicant

genedrive plc

 

Name of scheme

2007 Share Option Scheme

 

Period of return:

From:

01 December 2022

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

139,226 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

7,500 shares

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

131,726 shares

 

 

In order to co-terminate future block listing returns the Company confirms the following returns for the two block listings granted earlier in the month.

 

Name of applicant

genedrive plc

 

Name of scheme

2017 Share Option Scheme

 

Period of return:

From:

19 May 2023

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

1,150,588 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,150,588 shares

 

 

Name of applicant

genedrive plc

 

Name of scheme

Unapproved Share Option Scheme

 

Period of return:

From:

19 May 2023

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

2,668,144 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,668,144 shares

 

Name of contact:

Russ Shaw CFO

Telephone number of contact:

+44 (0)161 989 0245

 

For enquires:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Russ Shaw: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR Ltd (Media Relations & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFLFILETIIVIV
Date   Source Headline
10th Jan 20134:36 pmRNSDirector/PDMR Shareholding
9th Jan 20132:26 pmRNSHolding(s) in Company
17th Dec 20126:13 pmRNSDirector/PDMR Shareholding
13th Dec 20123:24 pmRNSResult of AGM
10th Dec 20129:45 amRNSHolding(s) in Company
7th Dec 20121:00 pmRNSCash Placing
21st Nov 20128:18 amRNSAnnual Report & Accounts and Notice of AGM
25th Oct 201210:54 amRNSHolding(s) in Company
24th Oct 201212:19 pmRNSHolding(s) in Company
24th Oct 20129:51 amRNSHolding(s) in Company
16th Oct 20127:00 amRNSFinal Results
4th Oct 20123:55 pmRNSDirector/PDMR Shareholding
10th Sep 20123:19 pmRNSPreliminary Results Date
6th Aug 20127:00 amRNSPre-Close Trading Update
3rd Aug 201211:58 amRNSProfessor Chris Potten
27th Jul 20124:09 pmRNSDirector's Shareholding and Additional Listing
10th Jul 20129:17 amRNSDirector/PDMR Shareholding
5th Jul 20127:00 amRNSTuberculosis test gains CE-IVD registration
3rd Apr 20124:53 pmRNSDirector/PDMR Shareholding
27th Mar 20129:13 amRNSAdditional Listing
14th Mar 20127:00 amRNSHalf Yearly Report
5th Mar 20127:00 amRNSEpistem Signs TB Channel Partner Agreement
22nd Feb 20128:18 amRNSHolding(s) in Company
21st Feb 20127:00 amRNSNotice of Results
20th Feb 20126:28 pmRNSHolding(s) in Company
10th Feb 20127:00 amRNSHolding(s) in Company
10th Jan 20121:18 pmRNSDirector/PDMR Shareholding
19th Dec 20115:54 pmRNSDirectors' shareholdings and issue of equity
25th Nov 201112:00 pmRNSCash Placing
9th Nov 20117:00 amRNS2011 Annual Report and Accounts & Notice of AGM
11th Oct 20117:00 amRNSFinal Results
7th Oct 201112:43 pmRNSDirector/PDMR Shareholding
5th Oct 20117:00 amRNSHuman DNA Identification Collaboration
27th Sep 20117:00 amRNSGenedriveT passes first in-field Tuberculosis test
4th Aug 20117:00 amRNSPre Close Trading Update
30th Jun 201112:00 pmRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSTuberculosis Diagnostic Collaboration
23rd Jun 20114:38 pmRNSHolding(s) in Company
19th May 20115:20 pmRNSHolding(s) in Company
19th Apr 201112:32 pmRNSHolding(s) in Company
19th Apr 201112:28 pmRNSHolding(s) in Company
8th Apr 20119:20 amRNSHolding(s) in Company
5th Apr 20112:34 pmRNSDirector/PDMR Shareholding
4th Apr 201112:41 pmRNSHolding(s) in Company
4th Apr 20119:35 amRNSHolding(s) in Company
29th Mar 20117:00 amRNSDirector/PDMR Shareholding
29th Mar 20117:00 amRNSInterim Results
28th Mar 20119:47 amRNSHolding(s) in Company
17th Mar 20119:23 amRNSRe Agreement - Replacement
17th Mar 20117:20 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.